fda warns against semaglutide The U.S. Food and Drug Administration (FDA) has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications People are overdosing on off-brand

Longitudinal effects of aging on serum total and free testosterone levels in healthy men

Whether thats worth 6080% more per month is a real question best decided with your diabetologist, not by price alone

Three of the five studies reported significant hair improvement and regrowth following tirzepatide treatment

Not lectures, not twenty browser tabs, just useful answers and gentle nudges that show up where you already track your day

Research into the efficacy of GLP-1 drugs found that, in a clinical trial setting, Semaglutide (Ozempic and Wegovy) could result in a 14.9% reduction in body weight over the course of 68 weeks